97 related articles for article (PubMed ID: 10692236)
1. Human mast cells express the hyaluronic-acid-binding isoform of CD44 and adhere to hyaluronic acid.
Fukui M; Whittlesey K; Metcalfe DD; Dastych J
Clin Immunol; 2000 Mar; 94(3):173-8. PubMed ID: 10692236
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronate binding assay study of transfected CD44 V4-V7 isoforms into the human gastric carcinoma cell line SC-M1.
Harn HJ; Shen KL; Liu CA; Ho LI; Yang LS; Yueh KC
J Pathol; 1998 Mar; 184(3):291-6. PubMed ID: 9614382
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
4. Interaction between CD44 and hyaluronic acid regulates human prostate cancer development.
Miyake H; Hara I; Okamoto I; Gohji K; Yamanaka K; Arakawa S; Saya H; Kamidono S
J Urol; 1998 Oct; 160(4):1562-6. PubMed ID: 9751413
[TBL] [Abstract][Full Text] [Related]
5. Origin and function of circulating CD44 in non-Hodgkin's lymphoma.
Ristämaki R; Joensuu H; Grön-Virta K; Salmi M; Jalkanen S
J Immunol; 1997 Mar; 158(6):3000-8. PubMed ID: 9058839
[TBL] [Abstract][Full Text] [Related]
6. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma inhibits CD44-hyaluronan interactions in normal human B lymphocytes.
Kryworuchko M; Diaz-Mitoma F; Kumar A
Exp Cell Res; 1999 Jul; 250(1):241-52. PubMed ID: 10388538
[TBL] [Abstract][Full Text] [Related]
8. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Cosio S; Prontera C; Bianchi R; Genazzani AR
Anticancer Res; 1997; 17(6D):4463-6. PubMed ID: 9494551
[TBL] [Abstract][Full Text] [Related]
9. Expression of transmembrane and soluble forms of CD44H in human myeloid cell lines and its regulation by hyaluronic acid.
Moreno CJ; Epuñan MJ; Minguell JJ
Haematologica; 2000 Mar; 85(3):321-2. PubMed ID: 10702826
[No Abstract] [Full Text] [Related]
10. The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides.
Wallach SB; Friedmann A; Naor D
Cancer Detect Prev; 2000; 24(1):33-45. PubMed ID: 10757121
[TBL] [Abstract][Full Text] [Related]
11. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation.
Zhu D; Bourguignon LY
Cell Motil Cytoskeleton; 1998; 39(3):209-22. PubMed ID: 9519902
[TBL] [Abstract][Full Text] [Related]
12. The role of CD44 during CD40 ligand-induced dendritic cell clustering and maturation.
Termeer C; Johannsen H; Braun T; Renkl A; Ahrens T; Denfeld RW; Lappin MB; Weiss JM; Simon JC
J Leukoc Biol; 2001 Nov; 70(5):715-22. PubMed ID: 11698490
[TBL] [Abstract][Full Text] [Related]
13. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells.
Draffin JE; McFarlane S; Hill A; Johnston PG; Waugh DJ
Cancer Res; 2004 Aug; 64(16):5702-11. PubMed ID: 15313910
[TBL] [Abstract][Full Text] [Related]
14. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix.
Zhu H; Mitsuhashi N; Klein A; Barsky LW; Weinberg K; Barr ML; Demetriou A; Wu GD
Stem Cells; 2006 Apr; 24(4):928-35. PubMed ID: 16306150
[TBL] [Abstract][Full Text] [Related]
15. CD44 Expression in Benign and Neoplastic Human Prostates.
Dhir R; Gau JT; Krill D; Bastacky S; Bahnson RR; Cooper DL; Becich MJ
Mol Diagn; 1997 Sep; 2(3):197-204. PubMed ID: 10462610
[TBL] [Abstract][Full Text] [Related]
16. Mast cell adhesion to bronchial smooth muscle in asthma specifically depends on CD51 and CD44 variant 6.
Girodet PO; Ozier A; Trian T; Begueret H; Ousova O; Vernejoux JM; Chanez P; Marthan R; Berger P; Tunon de Lara JM
Allergy; 2010 Aug; 65(8):1004-12. PubMed ID: 20121756
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD44 is cytotoxic to trabecular meshwork and retinal ganglion cells in vitro.
Choi J; Miller AM; Nolan MJ; Yue BY; Thotz ST; Clark AF; Agarwal N; Knepper PA
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):214-22. PubMed ID: 15623776
[TBL] [Abstract][Full Text] [Related]
18. The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.
Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Fanucchi A; Prontera C; Bianchi R; Genazzani AR
Anticancer Res; 1998; 18(1B):537-9. PubMed ID: 9568174
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronidase can modulate expression of CD44.
Stern R; Shuster S; Wiley TS; Formby B
Exp Cell Res; 2001 May; 266(1):167-76. PubMed ID: 11339835
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
Afify AM; Stern R; Michael CW
Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
